Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Evaluation of phage display discovered peptides as ligands for prostate-specific membrane antigen (PSMA).

Shen D, Xie F, Edwards WB.

PLoS One. 2013 Jul 25;8(7):e68339. doi: 10.1371/journal.pone.0068339. Print 2013.

2.

Screening of a specific peptide binding to VPAC1 receptor from a phage display peptide library.

Tang B, Li Z, Huang D, Zheng L, Li Q.

PLoS One. 2013;8(1):e54264. doi: 10.1371/journal.pone.0054264. Epub 2013 Jan 24.

3.

Selection of Single Chain Antibody Fragments for Targeting Prostate Specific Membrane Antigen: A Comparison Between Cell-based and Antigen-based Approach.

Rezaei J, RajabiBazl M, Ebrahimizadeh W, Dehbidi GR, Hosseini H.

Protein Pept Lett. 2016;23(4):336-42.

PMID:
26767429
4.

Development of novel peptide ligands modulating the enzyme activity of prostate-specific antigen.

Leinonen J, Wu P, Koivunen E, Närvänen A, Stenman UH.

Scand J Clin Lab Invest Suppl. 2000;233:59-64.

PMID:
11317943
5.

Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer.

Stephan C, Jung K, Diamandis EP, Rittenhouse HG, Lein M, Loening SA.

Urology. 2002 Jan;59(1):2-8. Review. No abstract available.

PMID:
11796270
6.

Prostate-specific membrane antigen and its truncated form PSM'.

Mlcochová P, Barinka C, Tykvart J, Sácha P, Konvalinka J.

Prostate. 2009 Apr 1;69(5):471-9. doi: 10.1002/pros.20894.

PMID:
19107881
7.

Further investigation of the epitope recognized by the new monoclonal antibody 2C9.

Kato K, Yoshikawa K, Taki T, Shitara K, Nakamura K, Hirota M, Hanai N, Nakamura K, Kokubo H, Mitsui K, Yamada Y, Honda N, Ueda R, Saga S, Fukatsu H.

Int J Urol. 2003 Aug;10(8):439-44.

8.
9.

Screening a phage display library for a novel FGF8b-binding peptide with anti-tumor effect on prostate cancer.

Wang W, Chen X, Li T, Li Y, Wang R, He D, Luo W, Li X, Wu X.

Exp Cell Res. 2013 May 1;319(8):1156-64. doi: 10.1016/j.yexcr.2013.02.007. Epub 2013 Mar 4.

PMID:
23466786
10.
11.

1alpha,25-Dihydroxyvitamin D3 down-regulates expression of prostate specific membrane antigen in prostate cancer cells.

Serda RE, Bisoffi M, Thompson TA, Ji M, Omdahl JL, Sillerud LO.

Prostate. 2008 May 15;68(7):773-83. doi: 10.1002/pros.20739.

PMID:
18247401
12.

Prostate cancer cell adhesion to bone marrow endothelium: the role of prostate-specific antigen.

Romanov VI, Whyard T, Adler HL, Waltzer WC, Zucker S.

Cancer Res. 2004 Mar 15;64(6):2083-9.

13.

Discovery of PSMA-specific peptide ligands for targeted drug delivery.

Jin W, Qin B, Chen Z, Liu H, Barve A, Cheng K.

Int J Pharm. 2016 Nov 20;513(1-2):138-147. doi: 10.1016/j.ijpharm.2016.08.048. Epub 2016 Aug 28.

PMID:
27582001
14.

Screening and identification of a peptide specifically targeted to NCI-H1299 from a phage display peptide library.

Zang L, Shi L, Guo J, Pan Q, Wu W, Pan X, Wang J.

Cancer Lett. 2009 Aug 18;281(1):64-70. doi: 10.1016/j.canlet.2009.02.021. Epub 2009 Mar 26.

PMID:
19327883
15.

[Screening and characterization of human phage Fab antibody gene to prostate specific membrane antigen].

Huang H, Huang J, Lin TX, Xu KW, Guo ZH, Jiang C, Han JL.

Zhonghua Nan Ke Xue. 2007 Jul;13(7):601-4. Chinese.

PMID:
17725301
16.

Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.

Larbanoix L, Burtea C, Ansciaux E, Laurent S, Mahieu I, Vander Elst L, Muller RN.

Peptides. 2011 Jun;32(6):1232-43. doi: 10.1016/j.peptides.2011.04.026. Epub 2011 May 6.

PMID:
21575663
17.

Potential application of antibody-mimicking peptides identified by phage display in immuno-magnetic separation of an antigen.

Hien TB, Maeng JH, Lee BH, Seong GH, Choo J, Lee EK.

J Biotechnol. 2012 Oct 31;161(3):213-20. doi: 10.1016/j.jbiotec.2012.06.039. Epub 2012 Jul 11.

PMID:
22796092
18.

Characterization of prostate-specific antigen binding peptides selected by phage display technology.

Ferrieu-Weisbuch C, Michel S, Collomb-Clerc E, Pothion C, Deléage G, Jolivet-Reynaud C.

J Mol Recognit. 2006 Jan-Feb;19(1):10-20.

PMID:
16312021
19.

Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion.

Romanov VI, Durand DB, Petrenko VA.

Prostate. 2001 Jun 1;47(4):239-51.

PMID:
11398171
20.

A dimeric peptide that binds selectively to prostate-specific membrane antigen and inhibits its enzymatic activity.

Aggarwal S, Singh P, Topaloglu O, Isaacs JT, Denmeade SR.

Cancer Res. 2006 Sep 15;66(18):9171-7.

Supplemental Content

Support Center